发明名称 Vaccine for shigella
摘要 Disclosed are immunogenic conjugates and therapeutic compositions that include such immunogenic conjugates. Also disclosed are methods of treating and/or inhibiting an Shigella sonnei infection. The disclosed immunogenic conjugates have the general structure: Pr—Sr—O—N═C-Kdo-OS wherein Pr is a carrier protein, Sr is an optional spacer moiety, Kdo is an 3-deoxy-D-manno-octulosonic acid or a derivative thereof, and OS is an oligosaccharide or polysaccharide obtained from S. sonnei. In specific examples, the immunogenic conjugates include the core oligosaccharide obtained from S. sonnei having the structure: ;wherein R is between 1 and 10 disaccharide repeat units.;In specific examples, the disaccharide repeat unit included in the immunogenic conjugate has the structure: α-L-AltNAcA-3-β-FucNAc4N-4-.
申请公布号 US8747863(B2) 申请公布日期 2014.06.10
申请号 US200913059051 申请日期 2009.08.14
申请人 The United States of America, as represented by the Secretary of the Department of Health and Human Services;National Research Council of Canada 发明人 Robbins John B.;Schneerson Rachel;Kubler-Kielb Joanna;Mocca Christopher P.;Vinogradov Evguenii
分类号 A61K49/00;A61K39/00;A61K47/00;A61K39/02;A61K39/385;A61K47/06 主分类号 A61K49/00
代理机构 代理人
主权项 1. An immunogenic conjugate comprising the structure of: Pr—Sr—O—N═C-Kdo-OSwherein Pr is a carrier protein, Sr is an optional spacer moiety, Kdo is 3-deoxy-D-manno-octulosonic acid, and OS comprises at least one oligosaccharide or polysaccharide obtained from S. sonnei.
地址 Washington DC US